MSA、CEA、NLR联合检测对小细胞肺癌的诊断及鉴别诊断效能
目的观察血清抗纺锤体抗体(MSA)、癌胚抗原(CEA)及全血中性粒细胞/淋巴细胞(NLR)联合检测对小细胞肺癌(SCLC)的诊断和鉴别诊断效能。方法SCLC患者53例(SCLC组)、肺腺癌(LAC)患者33例(LAC组)、肺鳞癌(LSC)患者29例(LSC组)、胃癌(GC)患者16例(GC组)、肝癌(HC)患者14例(HC组)、大肠癌(IC)患者13例(Ic组)、鼻咽癌(NC)患者12例(NC组),另选健康体检者45例(对照组),采用间接免疫荧光法检测血清MSA,化学发光法检测血清CEA,电阻抗法测算全血NLR,分析MSA、CEA、NLR单独和联合检测诊断SCLC的敏感度、特异度。结果与其余组...
Saved in:
Published in | 山东医药 Vol. 57; no. 47; pp. 13 - 16 |
---|---|
Main Author | |
Format | Magazine Article |
Language | Chinese |
Published |
南昌大学第二附属医院,江西南昌,330006%南昌大学公共卫生学院
2017
|
Subjects | |
Online Access | Get full text |
ISSN | 1002-266X |
DOI | 10.3969/j.issn.1002-266X.2017.47.004 |
Cover
Summary: | 目的观察血清抗纺锤体抗体(MSA)、癌胚抗原(CEA)及全血中性粒细胞/淋巴细胞(NLR)联合检测对小细胞肺癌(SCLC)的诊断和鉴别诊断效能。方法SCLC患者53例(SCLC组)、肺腺癌(LAC)患者33例(LAC组)、肺鳞癌(LSC)患者29例(LSC组)、胃癌(GC)患者16例(GC组)、肝癌(HC)患者14例(HC组)、大肠癌(IC)患者13例(Ic组)、鼻咽癌(NC)患者12例(NC组),另选健康体检者45例(对照组),采用间接免疫荧光法检测血清MSA,化学发光法检测血清CEA,电阻抗法测算全血NLR,分析MSA、CEA、NLR单独和联合检测诊断SCLC的敏感度、特异度。结果与其余组比较,SCLC组血清MSA阳性率高;与SCLC组比较,LAC组血清CEA、全血NLR阳性率高,对照组血清CEA、全血NLR阳性率低;P均〈0.05。NLR单独检测诊断SCLC的灵敏度最高(43.40%),MSA单独检测诊断的特异度最高(96.58%)。MSA+CEA+NLR三者联合检测诊断SCLC的敏感度(并联,81.84%)、特异度(串联,100.00%)最高。MSA与CEA一致性较高(κ=0.654);MSA与NLR一致性中等(κ=0.451)。结论血清MSA、CEA及全血NLR联合检测有助于SCLC的诊断和鉴别诊断。 |
---|---|
Bibliography: | TAN Liming1, ZHENG Wei, FU Huiying, MENG Yimei, GUAN Xiaolin, WU Sifan, LONG Tingting, WANG Qiaohua, WU Yang, ZENG Tingting, TIAN Yongjian, YU Jianlin, CHEN Juanjuan, LI Hua, CAO Liping (1 The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China) 37-1156/R small cell lung cancer; anti-spindle antibody; carcinoembryonic antigen; neutrophils; lymphocytes Objective To observe the application value of detection of serum anti-spindle antibodies ( MSA), carci- noembryonic antigen (CEA), whole blood neutrophils/lymphocytes (NLR) in diagnosis and differential diagnosis of small cell lung cancer (SCLC). Methods Fifty-three patients with SCLC (SCLC group) , 33 patients with lung adenocarcino- ma (LAC) (LAC group), 29 patients with lung squamous cell carcinoma (LSC) (LSC group), 16 patients with gastric carcinoma (GC) (GC group), 14 patients with hepatic carcinoma (HC) (HC group), 13 patients with colorectal cancer (CC) (group CC), 12 patients with nasopharyngeal carcinoma (NC) (NC group), and 45 healt |
ISSN: | 1002-266X |
DOI: | 10.3969/j.issn.1002-266X.2017.47.004 |